Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.
Hidenobu IshiiKoichi AzumaAkihiko KawaharaTakashi KinoshitaNorikazu MatsuoYoshiko NaitoTakaaki TokitoKazuhiko YamadaJun AkibaTomoaki HoshinoPublished in: Thoracic cancer (2020)
High CD73 expression may predict a favorable response to immune checkpoint inhibitors in NSCLC patients, especially those harboring EGFR mutations.